Predictive Value of Tumor Regression Grading on the Prognosis of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Systematic Review and Meta-Analysis

医学 荟萃分析 内科学 肿瘤科 分级(工程) 危险系数 化疗 分布式文件系统 置信区间 癌症 新辅助治疗 比例危险模型 出版偏见 乳腺癌 计算机科学 土木工程 工程类 计算机安全
作者
Ronald Wu,Shuying Lin,Junze Chen,Gang Wang,Lulu Han
出处
期刊:Clinical and translational gastroenterology [Lippincott Williams & Wilkins]
卷期号:16 (7): e00860-e00860 被引量:11
标识
DOI:10.14309/ctg.0000000000000860
摘要

INTRODUCTION: Tumor regression grade (TRG) after neoadjuvant chemotherapy is recognized as a significant and favorable prognostic indicator in various cancer types. However, this relationship remains less defined and has not been systematically investigated in locally advanced gastric cancer (LAGC). To address this gap, we conducted a meta-analysis aimed at assessing the prognostic influence of tumor regression after preoperative therapy on disease-free survival (DFS) and overall survival (OS) among patients with LAGC. METHODS: A systematic search was conducted across the following databases: PubMed, Web of Science, Embase, Cochrane, WF, CNKI, SinoMed, and VIP. The primary outcomes included DFS and OS, estimated using hazard ratios (HRs) and corresponding 95% confidence intervals (CIs). Subsequently, either the fixed-effects model or the random-effects model was used to compute HR and 95% CI based on the results of heterogeneity analysis. RESULTS: A total of 11 studies, comprising 2,733 patients, were included in the final analysis. The results indicated that a lower TRG was associated with prolonged DFS (HR 0.53, 95% CI 0.32-0.88) and prolonged OS (HR 0.59, 95% CI 0.39-0.87) in patients with LAGC who received neoadjuvant chemotherapy. Sensitivity analysis demonstrated that no single study significantly influenced the results for both DFS and OS. Publication bias was identified in the meta-analysis for OS, whereas no publication bias was detected in the meta-analysis for DFS. DISCUSSION: A lower TRG score is associated with improved DFS and OS in patients with LAGC receiving neoadjuvant chemotherapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田様的应助被科研通管家采纳,获得10
刚刚
ding的应助被科研通管家采纳,获得10
刚刚
科研通AI65的应助被科研通管家采纳,获得10
刚刚
传奇3的应助被科研通管家采纳,获得10
刚刚
刚刚
luyue9406的应助被科研通管家采纳,获得10
刚刚
霁月发布了新的文献求助10
刚刚
天天快乐的应助被科研通管家采纳,获得10
刚刚
霁月发布了新的文献求助10
刚刚
霁月发布了新的文献求助10
1秒前
Lucas的应助被科研通管家采纳,获得30
1秒前
科研通AI65的应助被科研通管家采纳,获得10
1秒前
李爱国的应助被xy采纳,获得10
1秒前
Youdge的应助被科研通管家采纳,获得20
1秒前
Youdge的应助被科研通管家采纳,获得20
1秒前
天天快乐的应助被科研通管家采纳,获得10
1秒前
SciGPT的应助被科研通管家采纳,获得10
1秒前
Akim的应助被科研通管家采纳,获得10
1秒前
2秒前
科目三的应助被科研通管家采纳,获得10
2秒前
2秒前
糖果悠悠的应助被小红采纳,获得10
2秒前
情怀的应助被科研通管家采纳,获得10
2秒前
Feng的应助被科研通管家采纳,获得20
2秒前
李爱国的应助被科研通管家采纳,获得10
2秒前
共享精神的应助被科研通管家采纳,获得10
2秒前
Lucas的应助被科研通管家采纳,获得10
2秒前
充电宝的应助被科研通管家采纳,获得10
2秒前
烟花的应助被科研通管家采纳,获得10
3秒前
十万毫升硫酸钡完成签到 ,获得积分10
3秒前
852的应助被科研通管家采纳,获得10
3秒前
Youdge的应助被科研通管家采纳,获得10
3秒前
Youdge的应助被科研通管家采纳,获得20
3秒前
繁荣的瑛的应助被科研通管家采纳,获得10
3秒前
小二郎的应助被科研通管家采纳,获得10
3秒前
bkagyin的应助被科研通管家采纳,获得10
3秒前
斯文败类的应助被科研通管家采纳,获得10
3秒前
2799完成签到,获得积分10
4秒前
4秒前
NexusExplorer的应助被科研通管家采纳,获得10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187328
求助须知:如何正确求助?哪些是违规求助? 9575427
关于积分的说明 21841244
捐赠科研通 7784994
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559375
邀请新用户注册赠送积分活动 2481820